This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.
Deadlines:
PAR-20-124 Expiration Date May 3, 2022
NOTE: Applicants with current active awards funded under PAR-16-099 “NARMS Cooperative Agreement to Enhance and Strengthen Antimicrobial Resistance Surveillance in Retail Food Specimens (U01)” are eligible to apply to this FOA. However, if a new award is issued under this FOA to the applicant organization, the applicant agrees to terminate the award that was issued under PAR-16-099 and agrees to forfeit any remaining funds left on their previous award. Applicants cannot have both the award issued under PAR-16-099 and the new award issued under this FOA.
Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect):
YR 01: $200,000
YR 02: $200,000
YR 03: $200,000
YR 04: $200,000
YR 05: $200,000
The total number of years for which federal support has been approved (project period) will be shown in the "Notice of Award." This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive award and any subsequent non-competitive continuation award(s).
